Literature DB >> 7529223

Spontaneous regression of metastatic renal cell carcinoma following palliative irradiation of the primary tumour.

M P MacManus1, R J Harte, S Stranex.   

Abstract

A 58 years old man presented with a bulky renal primary tumour, paratracheal lymphadenopathy and multiple pulmonary metastases. Spontaneous regression of intrathoracic metastases occurred after low dose palliative irradiation of the primary tumour. Serum levels of Interleukin-2 receptor were elevated during the period of tumour regression but concentrations of other cytokines were normal. Progressive abdominal disease eventually caused death. Autopsy confirmed the presence of renal cell carcinoma with intrathoracic metastases.

Entities:  

Mesh：

Year:  1994        PMID： 7529223     DOI： 10.1007/bf02940567

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  14 in total

1.  Regression in renal cell carcinoma as re-expression of cell death in kidney development.

Authors:  F Pansera
Journal:  Perspect Biol Med       Date:  1992       Impact factor: 1.416

2.  Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies.

Authors:  W H West
Journal:  Cancer Treat Rev       Date:  1989-06       Impact factor: 12.111

Review 3.  Growth factors and cancer.

Authors:  A S Goustin; E B Leof; G D Shipley; H L Moses
Journal:  Cancer Res       Date:  1986-03       Impact factor: 12.701

Review 4.  The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma.

Authors:  M Kjaer
Journal:  Cancer Treat Rev       Date:  1988-09       Impact factor: 12.111

5.  Intralesional application of recombinant human tumor necrosis factor alpha induces local tumor regression in patients with advanced malignancies.

Authors:  H H Bartsch; K Pfizenmaier; M Schroeder; G A Nagel
Journal:  Eur J Cancer Clin Oncol       Date:  1989-02

6.  Regression of metastatic renal cell carcinoma after cytoreductive nephrectomy.

Authors:  S G Marcus; P L Choyke; R Reiter; G S Jaffe; R B Alexander; W M Linehan; S A Rosenberg; M M Walther
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

7.  Interferon therapy for the treatment of renal cancer.

Authors:  J A Neidhart
Journal:  Cancer       Date:  1986-04-15       Impact factor: 6.860

8.  The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma.

Authors:  J E Montie; B H Stewart; R A Straffon; L H Banowsky; C B Hewitt; D K Montague
Journal:  J Urol       Date:  1977-03       Impact factor: 7.450

9.  Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies.

Authors:  J Atzpodien; A Körfer; C R Franks; H Poliwoda; H Kirchner
Journal:  Lancet       Date:  1990-06-23       Impact factor: 79.321

10.  Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours.

Authors:  P Lissoni; S Barni; R Rescaldani; F Rovelli; G Tancini
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640
View more
  9 in total

Review 1.  The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

Authors:  Kobe Reynders; Tim Illidge; Shankar Siva; Joe Y Chang; Dirk De Ruysscher
Journal:  Cancer Treat Rev       Date:  2015-03-28       Impact factor: 12.111

2.  The differential role of human macrophage in triggering secondary bystander effects after either gamma-ray or carbon beam irradiation.

Authors:  Chen Dong; Mingyuan He; Wenzhi Tu; Teruaki Konishi; Weili Liu; Yuexia Xie; Bingrong Dang; Wenjian Li; Yukio Uchihori; Tom K Hei; Chunlin Shao
Journal:  Cancer Lett       Date:  2015-04-17       Impact factor: 8.679

Review 3.  Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.

Authors:  Jennifer A Wargo; Alexandre Reuben; Zachary A Cooper; Kevin S Oh; Ryan J Sullivan
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

Review 4.  Spontaneous regression of colorectal cancer: a review of cases from 1900 to 2005.

Authors:  Ayman S Abdelrazeq
Journal:  Int J Colorectal Dis       Date:  2006-12-05       Impact factor: 2.796

Review 5.  Combinations of immunotherapy and radiation in cancer therapy.

Authors:  Ralph E Vatner; Benjamin T Cooper; Claire Vanpouille-Box; Sandra Demaria; Silvia C Formenti
Journal:  Front Oncol       Date:  2014-11-28       Impact factor: 6.244

6.  Abscopal effect in the radio and immunotherapy.

Authors:  Alina M Pevzner; Matvey M Tsyganov; Marina K Ibragimova; Nikolai V Litvyakov
Journal:  Radiat Oncol J       Date:  2021-10-25

Review 7.  A Patient-Level Data Meta-analysis of the Abscopal Effect.

Authors:  Steven J Hatten; Eric J Lehrer; Jenn Liao; Congzhou M Sha; Daniel M Trifiletti; Shankar Siva; Sean M McBride; David Palma; Sheldon L Holder; Nicholas G Zaorsky
Journal:  Adv Radiat Oncol       Date:  2022-03-03

Review 8.  Abscopal Effect of Radiotherapy in the Immunotherapy Era: Systematic Review of Reported Cases.

Authors:  Nergiz Dagoglu; Sule Karaman; Hale B Caglar; Ethem N Oral
Journal:  Cureus       Date:  2019-02-20

9.  Spontaneous regression of micro-metastases following primary tumor excision: a critical role for primary tumor secretome.

Authors:  Lee Shaashua; Anabel Eckerling; Boaz Israeli; Gali Yanovich; Ella Rosenne; Suzana Fichman-Horn; Ido Ben Zvi; Liat Sorski; Rita Haldar; Ronit Satchi-Fainaro; Tamar Geiger; Erica K Sloan; Shamgar Ben-Eliyahu
Journal:  BMC Biol       Date:  2020-11-06       Impact factor: 7.431
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.